![]() |
市场调查报告书
商品编码
1876752
宠物CBD产品市场预测至2032年:按产品、频谱、宠物类型、应用、通路和地区分類的全球分析Pet CBD Products Market Forecasts to 2032 - Global Analysis By Product (Oils & Tinctures, Treats & Chews, Capsules & Softgels and Supplements), Spectrum, Pet Type, Application, Distribution Channel and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球宠物 CBD 产品市场价值将达到 8.741 亿美元,到 2032 年将达到 27.846 亿美元,在预测期内的复合年增长率为 18.0%。
宠物专用CBD产品是源自大麻的配方,旨在支持宠物(例如犬猫)的健康和福祉。这些产品含有大麻二酚(CBD),这是一种非精神活性化合物,以其潜在的治疗益处而闻名,包括缓解焦虑、发炎、疼痛和癫痫发作。宠物专用CBD产品有多种形式,包括油剂、零食、胶囊、咀嚼片和外用产品,安全合法(THC含量低于0.3%),且配方适口,动物偏好。在兽医的指导下,这些产品越来越多地被用于宠物整体护理方案中,以提高宠物的生命品质并控制慢性疾病,且不会产生任何致幻作用。
宠物拟人化与健康趋势
宠物日益拟人化是宠物CBD产品市场的主要驱动力,因为饲主主人越来越倾向于寻求宠物健康的整体解决方案。 CBD产品被认为是一种天然的替代疗法,可以缓解焦虑、疼痛和老龄化相关症状。随着宠物被视为家庭成员,对安全、无成瘾性和治疗性配方的需求持续增长。这种消费行为的转变,加上宠物医疗保健支出不断增加,正迅速推动已开发经济体和新兴经济体的市场扩张。
监理不确定性
监管的不确定性仍是宠物CBD产品市场的主要阻碍因素。各国和各州不同的法律体制导致产品核准、标籤和分销方面存在不确定性。缺乏动物CBD使用方面的标准化指南限制了兽医的建议和消费者的信心。此外,执法不一致和不断变化的法规阻碍了新进入者的市场准入,并使扩大策略变得复杂。在更明确的法规出台之前,这种不确定性将继续给寻求可靠CBD解决方案的製造商、零售商和宠物饲主带来挑战。
产品创新与品牌塑造
产品创新和品牌建立为宠物CBD产品市场带来了巨大的成长机会。各公司正在开发多种产品形式,包括调味零食、油剂、胶囊和外用产品,以满足宠物的偏好和健康需求。加强品牌建立策略,例如提高成分来源的透明度和进行第三方检测,将有助于建立消费者的信任和忠诚度。随着人们对CBD益处的认识不断提高,针对特定症状(例如关节疼痛、焦虑)的创新给药系统和配方正在推动产品差异化。这波创新浪潮有望加速CBD产品的普及,并扩大市场覆盖范围。
兽医建议有限
兽医认可度有限对宠物CBD产品市场构成威胁。由于缺乏临床数据和监管风险,许多专家仍持谨慎态度。缺乏强而有力的兽医支持,宠物饲主可能不愿意使用CBD产品,尤其是在宠物患有慢性病或严重的情况下。这种医学支援的缺失影响了产品的可信度,并阻碍了其被大众广泛接受。为了克服这一障碍,企业必须加强研发、教育投入,并与兽医组织合作,以建立循证支持并推广负责任的使用。
新冠疫情对宠物CBD产品市场产生了复杂的影响。虽然供应链中断和经济不确定性最初减缓了市场成长,但宠物饲养量的增加和居家时间的延长推动了人们对健康解决方案的需求。饲主更加关注宠物的行为和健康问题,从而带动了对舒缓和治疗性CBD产品的需求。疫情封锁期间,电子商务通路蓬勃发展,改变了消费者的购买习惯,并扩大了产品的取得管道。疫情后的復苏继续支撑着市场的发展势头,数位平台和健康意识增强的消费者将推动市场实现持续的长期成长。
预计在预测期内,CBD隔离群市场将占据最大的市场份额。
由于其纯度高、均一且符合法律法规,CBD隔离群物预计将在预测期内占据最大的市场份额。隔离群配方含有99%的纯CBD,不含THC和其他大麻素,因此非常适合宠物使用。这些产品剂量可预测,且精神活性作用风险极低,因此深受谨慎的宠物饲主和兽医的青睐。此外,它们还以多种形式供应,包括零食、油剂和胶囊,这进一步巩固了其市场主导地位,尤其是在监管标准严格的地区。
预计在预测期内,电子商务领域将呈现最高的复合年增长率。
预计在预测期内,电子商务领域将保持最高的成长率,这主要得益于其便利性、产品多样性和日益增强的数位意识。线上平台不仅方便消费者购买CBD产品,还提供丰富的教育内容、使用者评价和订阅服务。疫情加速了数位化进程,消费者更倾向于直接配送宠物保健产品。电子商务也帮助小众品牌绕过传统零售通路,触达全球客户。这种消费行为的转变预计将持续推动电子商务的快速成长,并重塑分销策略。
由于宠物拥有率上升、可支配收入增加以及人们对天然疗法的认知不断提高,预计亚太地区将在预测期内占据最大的市场份额。在中国、日本和印度等国家,宠物人性化程度的提高推动了对整体护理产品的需求。不断扩展的电子商务基础设施和有利的监管政策进一步提升了市场准入。本地製造商和国际品牌都在投资产品在地化和教育,使亚太地区成为宠物CBD的关键成长中心。
在预测期内,北美预计将实现最高的复合年增长率,这主要得益于其先进的兽医基础设施、较高的消费者意识以及不断完善的CBD相关立法。美国和加拿大引领宠物健康潮流,饲主积极寻求天然疗法来缓解宠物的焦虑、疼痛和老龄化症状。较高的可支配收入和高级产品的广泛普及推动了CBD的快速普及。此外,强大的电子商务网路以及兽医领域对CBD日益增长的接受度也是促成北美成为成长最快的区域市场的重要因素。
According to Stratistics MRC, the Global Pet CBD Products Market is accounted for $874.1 million in 2025 and is expected to reach $2,784.6 million by 2032 growing at a CAGR of 18.0% during the forecast period. Pet CBD products are hemp-derived formulations designed to support the health and wellness of companion animals such as dogs and cats. These products contain cannabidiol (CBD), a non-psychoactive compound known for its potential therapeutic benefits, including relief from anxiety, inflammation, pain, and seizures. Available in various forms-such as oils, treats, capsules, chews, and topicals-pet CBD products are formulated to be safe, legal (with less than 0.3% THC), and palatable for animals. They are increasingly used in holistic pet care routines, often under veterinary guidance, to enhance quality of life and manage chronic conditions without intoxicating effects.
Pet Humanization & Wellness Trends
The growing trend of pet humanization is a major driver of the pet CBD products market, as owners increasingly seek holistic wellness solutions for their animals. CBD products are viewed as natural alternatives for managing anxiety, pain, and age-related conditions. With pets treated as family members, demand for safe, non-intoxicating, and therapeutic formulations continues to rise. This shift in consumer behavior, supported by increased spending on pet healthcare and wellness, is fueling rapid market expansion across both developed and emerging regions.
Regulatory Ambiguity
Regulatory ambiguity remains a key restraint in the pet CBD products market. Varying legal frameworks across countries and states create uncertainty around product approval, labeling, and distribution. The lack of standardized guidelines for CBD use in animals limits veterinary endorsement and consumer confidence. Additionally, inconsistent enforcement and evolving legislation hinder market entry for new players and complicate expansion strategies. Until clearer regulations are established, this ambiguity will continue to challenge manufacturers, retailers, and pet owners seeking reliable CBD solutions.
Product Innovation & Branding
Product innovation and branding presents a significant opportunity for growth in the pet CBD market. Companies are developing diverse formats-such as flavored treats, oils, capsules, and topicals-tailored to pet preferences and health needs. Enhanced branding strategies, including transparency in sourcing and third-party testing, build consumer trust and loyalty. As awareness of CBD's benefits grows, innovative delivery systems and targeted formulations for specific conditions (e.g., joint pain, anxiety) are driving differentiation. This innovation wave is expected to accelerate adoption and expand market reach.
Limited Veterinary Endorsement
Limited veterinary endorsement poses a threat to the pet CBD products market, as many professionals remain cautious due to insufficient clinical data and regulatory risks. Without strong support from veterinarians, pet owners may hesitate to adopt CBD products, especially for chronic or serious conditions. This lack of medical validation affects credibility and slows mainstream acceptance. To overcome this barrier, companies must invest in research, education, and partnerships with veterinary institutions to build evidence-based support and encourage responsible usage.
The Covid-19 pandemic had a mixed impact on the pet CBD products market. While supply chain disruptions and economic uncertainty initially slowed growth, increased pet adoption and time spent at home boosted interest in wellness solutions. Owners became more attentive to pets' behavioral and health issues, driving demand for calming and therapeutic CBD products. E-commerce channels flourished during lockdowns, reshaping purchasing habits and expanding access. Post-pandemic recovery continues to support market momentum, with digital platforms and health-conscious consumers sustaining long-term growth.
The CBD isolate segment is expected to be the largest during the forecast period
The CBD isolate segment is expected to account for the largest market share during the forecast period, due to its purity, consistency, and legal compliance. Isolate formulations contain 99% pure CBD, free from THC and other cannabinoids, making them ideal for pet use. These products offer predictable dosing and minimal risk of psychoactive effects, which appeals to cautious pet owners and veterinarians. Their widespread availability across treats, oils, and capsules further supports dominance, especially in regions with strict regulatory standards.
The e-commerce segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the e-commerce segment is predicted to witness the highest growth rate, due to convenience, product variety, and digital awareness. Online platforms offer easy access to CBD products, along with educational content, reviews, and subscription models. The pandemic accelerated digital adoption, and consumers now prefer direct-to-door delivery for pet wellness items. E-commerce also enables niche brands to reach global audiences, bypassing traditional retail barriers. This shift in buying behavior is expected to sustain rapid growth and reshape distribution strategies.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising pet ownership, growing disposable incomes, and increasing awareness of natural health solutions. Countries like China, Japan, and India are experiencing a surge in pet humanization, driving demand for holistic care products. Expanding e-commerce infrastructure and favorable regulatory developments further enhance market accessibility. Local manufacturers and global brands are investing in product localization and education, positioning Asia Pacific as a key growth hub for pet CBD.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure, strong consumer awareness, and progressive CBD legislation. The U.S. and Canada lead in pet wellness trends, with owners actively seeking natural remedies for anxiety, pain, and aging-related conditions. High disposable incomes and widespread availability of premium products support rapid adoption. Additionally, robust e-commerce networks and increasing veterinary openness to CBD contribute to North America's position as the fastest-growing regional market.
Key players in the market
Some of the key players in Pet CBD Products Market include Charlotte's, Medterra, King Kanine, Pet Releaf, Innovet Pet, Green Roads, Honest Paws, cbdMD, Inc., CBDfx, Canna-Pet, Paw CBD, HempMy Pet, HolistaPet, Joy Organics and PureKana.
In September 2025, The multi-year partnership between Charlotte Hornets and Judi Health marks a strategic alignment of athletic branding and healthcare innovation: Judi Health becomes the exclusive jersey-patch partner for the Hornets, showcasing its healthcare-tech leadership on the NBA stage and amplifying its mission to transform benefit administration across the U.S.
In April 2025, Nutriband Inc. has entered into a partnership agreement with Charlotte FC, leveraging the collaboration to boost its brand visibility-particularly for its "AI Tape" product made in the Charlotte region-and spotlight its AVERSA(TM) abuse-deterrent patch technology.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.